USD 0.05
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 22.84 Million USD | 21.64% |
2022 | 18.78 Million USD | -3.44% |
2021 | 19.45 Million USD | 34.77% |
2020 | 14.43 Million USD | -58.15% |
2019 | 34.49 Million USD | 63.29% |
2018 | 21.12 Million USD | 7.63% |
2017 | 19.62 Million USD | 54580.37% |
2016 | 35.89 Thousand USD | 240.71% |
2015 | 10.53 Thousand USD | -66.55% |
2014 | 31.49 Thousand USD | -42.39% |
2013 | 54.67 Thousand USD | 108.7% |
2012 | 26.19 Thousand USD | 77.22% |
2011 | 14.78 Thousand USD | -13.1% |
2010 | 17.01 Thousand USD | -36.59% |
2009 | 26.82 Thousand USD | -44.49% |
2008 | 48.33 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 23.05 Million USD | 0.88% |
2024 Q2 | 23.92 Million USD | 3.77% |
2023 FY | 22.84 Million USD | 21.64% |
2023 Q3 | 21.36 Million USD | 12.9% |
2023 Q2 | 18.92 Million USD | -4.09% |
2023 Q1 | 19.72 Million USD | 5.03% |
2023 Q4 | 22.84 Million USD | 6.97% |
2022 Q3 | 17.63 Million USD | -3.9% |
2022 Q4 | 18.78 Million USD | 6.54% |
2022 FY | 18.78 Million USD | -3.44% |
2022 Q1 | 17.94 Million USD | -7.77% |
2022 Q2 | 18.34 Million USD | 2.26% |
2021 Q3 | 15.3 Million USD | -5.33% |
2021 Q2 | 16.16 Million USD | 5.38% |
2021 FY | 19.45 Million USD | 34.77% |
2021 Q4 | 19.45 Million USD | 27.09% |
2021 Q1 | 15.34 Million USD | 6.28% |
2020 Q3 | 30.42 Million USD | 0.18% |
2020 Q1 | 35.37 Million USD | 2.57% |
2020 FY | 14.43 Million USD | -58.15% |
2020 Q2 | 30.37 Million USD | -14.15% |
2020 Q4 | 14.43 Million USD | -52.56% |
2019 FY | 34.49 Million USD | 63.29% |
2019 Q2 | 26.28 Million USD | 11.55% |
2019 Q4 | 34.49 Million USD | 22.15% |
2019 Q3 | 28.23 Million USD | 7.42% |
2019 Q1 | 23.56 Million USD | 11.55% |
2018 Q2 | 22.57 Million USD | 7.24% |
2018 FY | 21.12 Million USD | 7.63% |
2018 Q4 | 21.12 Million USD | -10.65% |
2018 Q3 | 23.63 Million USD | 4.73% |
2018 Q1 | 21.04 Million USD | 7.25% |
2017 Q3 | 5.44 Million USD | 57.92% |
2017 Q4 | 19.62 Million USD | 260.36% |
2017 Q2 | 3.44 Million USD | 26.0% |
2017 Q1 | 2.73 Million USD | 7526.25% |
2017 FY | 19.62 Million USD | 54580.37% |
2016 Q4 | 35.89 Thousand USD | 17.97% |
2016 Q2 | 10.06 Thousand USD | 34.0% |
2016 Q1 | 7509.78 USD | -28.71% |
2016 Q3 | 30.42 Thousand USD | 202.34% |
2016 FY | 35.89 Thousand USD | 240.71% |
2015 Q4 | 10.53 Thousand USD | 29.4% |
2015 Q1 | 10.9 Thousand USD | -65.39% |
2015 FY | 10.53 Thousand USD | -66.55% |
2015 Q2 | 7239.93 USD | -33.58% |
2015 Q3 | 8140.78 USD | 12.44% |
2014 Q2 | 29.37 Thousand USD | -43.29% |
2014 FY | 31.49 Thousand USD | -42.39% |
2014 Q4 | 31.49 Thousand USD | 12.03% |
2014 Q3 | 28.11 Thousand USD | -4.31% |
2014 Q1 | 51.8 Thousand USD | -5.24% |
2013 Q3 | 36.23 Thousand USD | 19.31% |
2013 Q4 | 54.67 Thousand USD | 50.89% |
2013 Q2 | 30.36 Thousand USD | -14.5% |
2013 Q1 | 35.51 Thousand USD | 35.59% |
2013 FY | 54.67 Thousand USD | 108.7% |
2012 Q3 | 9184.66 USD | -24.36% |
2012 Q2 | 12.14 Thousand USD | -34.14% |
2012 Q1 | 18.43 Thousand USD | 24.71% |
2012 Q4 | 26.19 Thousand USD | 185.21% |
2012 FY | 26.19 Thousand USD | 77.22% |
2011 Q2 | 7767.52 USD | -55.17% |
2011 Q1 | 17.32 Thousand USD | 1.85% |
2011 Q3 | 6713.89 USD | -13.56% |
2011 Q4 | 14.78 Thousand USD | 120.17% |
2011 FY | 14.78 Thousand USD | -13.1% |
2010 Q3 | 35.23 Thousand USD | 394.24% |
2010 FY | 17.01 Thousand USD | -36.59% |
2010 Q4 | 17.01 Thousand USD | -51.72% |
2010 Q2 | 7129.30 USD | -77.21% |
2010 Q1 | 31.28 Thousand USD | 16.6% |
2009 Q3 | 24.68 Thousand USD | 0.35% |
2009 Q2 | 24.59 Thousand USD | 30.0% |
2009 FY | 26.82 Thousand USD | -44.49% |
2009 Q1 | 18.91 Thousand USD | -60.86% |
2009 Q4 | 26.82 Thousand USD | 8.71% |
2008 FY | 48.33 Thousand USD | 0.0% |
2008 Q2 | 22.19 Thousand USD | 108.68% |
2008 Q3 | 6556.77 USD | -70.46% |
2008 Q4 | 48.33 Thousand USD | 637.15% |
2008 Q1 | 10.63 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 2.47 Billion USD | 99.075% |
Addus HomeCare Corporation | 317.73 Million USD | 92.809% |
AirSculpt Technologies, Inc. | 129.56 Million USD | 82.364% |
Amedisys, Inc. | 940.38 Million USD | 97.57% |
American Oncology Network, Inc. | 368.72 Million USD | 93.803% |
Astrana Health, Inc. | 522.59 Million USD | 95.628% |
Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 98.705% |
IMAC Holdings, Inc. | 1.89 Million USD | -1104.629% |
biote Corp. | 191.84 Million USD | 88.09% |
Cryo-Cell International, Inc. | 72.25 Million USD | 68.376% |
Cross Country Healthcare, Inc. | 205.92 Million USD | 88.904% |
COMPASS Pathways plc | 50.24 Million USD | 54.523% |
DocGo Inc. | 185.28 Million USD | 87.668% |
The Ensign Group, Inc. | 2.68 Billion USD | 99.147% |
Healthcare Services Group, Inc. | 346.56 Million USD | 93.407% |
InnovAge Holding Corp. | 247.85 Million USD | 90.781% |
The Joint Corp. | 62.37 Million USD | 63.371% |
LifeStance Health Group, Inc. | 804.27 Million USD | 97.159% |
Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -499.528% |
ModivCare Inc. | 1.61 Billion USD | 98.582% |
NewGenIvf Group Limited | 1.24 Million USD | -1740.531% |
Novo Integrated Sciences, Inc. | 11.06 Million USD | -106.517% |
Option Care Health, Inc. | 1.9 Billion USD | 98.802% |
P3 Health Partners Inc. | 427.3 Million USD | 94.653% |
P3 Health Partners Inc. | 427.3 Million USD | 94.653% |
The Pennant Group, Inc. | 394.17 Million USD | 94.203% |
Surgery Partners, Inc. | 3.65 Billion USD | 99.375% |
Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -2410.68% |
Talkspace, Inc. | 23.57 Million USD | 3.08% |
Talkspace, Inc. | 23.57 Million USD | 3.08% |
The Oncology Institute, Inc. | 162.39 Million USD | 85.93% |
The Oncology Institute, Inc. | 162.39 Million USD | 85.93% |